Jack W. Callicutt - 02 Jan 2026 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Reporting relationship: Chief Financial Officer
Issuer ticker: GALT
Reported as of: 02 Jan 2026
Net transaction value: -$233,388
SEC form: 4
Accepted by SEC: 06 Jan 2026, 16:54:05 UTC
Prior SEC filing: 19 Nov 2025
Next SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: Jack W. Callicutt

Key filing fact

Jack W. Callicutt filed Form 4 for GALECTIN THERAPEUTICS INC (GALT) on 06 Jan 2026.

Key facts

This page summarizes Jack W. Callicutt's Form 4 filing for GALECTIN THERAPEUTICS INC (GALT).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jan 2026, 16:54.

Change

Previous filing in this sequence was filed on 19 Nov 2025.
Current net transaction value: -$233,388.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001266773 Primary reporting owner

CALLICUTT JACK W

Relationship: Chief Financial Officer
Address: C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS
Signature: Jack W. Callicutt
Signature date: 06 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GALT transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +60,000
Change %: +788%
Price: $0.000000
Shares after: 67,614
Date: 02 Jan 2026
Ownership: Direct
Footnotes: F3

GALT transaction

Common Stock

Sale

Transaction value: $58,394
Shares: -13,914
Change %: -21%
Price: $4.20
Shares after: 53,700
Date: 02 Jan 2026
Ownership: Direct
Footnotes: F1, F2

GALT transaction

Common Stock

Sale

Transaction value: $100,298
Shares: -25,732
Change %: -48%
Price: $3.90
Shares after: 27,968
Date: 05 Jan 2026
Ownership: Direct
Footnotes: F1, F5

GALT transaction

Common Stock

Sale

Transaction value: $74,695
Shares: -20,354
Change %: -73%
Price: $3.67
Shares after: 7,614
Date: 06 Jan 2026
Ownership: Direct
Footnotes: F1, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GALT transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -60,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $0.000000
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.

Footnote F2

The shares were sold in multiple transactions at prices ranging from $4.00 to $4.34. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Footnote F3

Shares of common stock acquired for no additional consideration resulting from vesting of Restricted Stock Units.

Footnote F4

Restricted Stock Units disposed upon conversion into shares of common stock pursuant to vesting on January 2, 2026.

Footnote F5

The shares were sold in multiple transactions at prices ranging from $3.81 to $4.06. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Footnote F6

The shares were sold in multiple transactions at prices ranging from $3.47 to $3.81. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.